FA
CELG

Fagan Associates’s Celgene Corp CELG Stock Holding History

Fagan Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-28,328
Closed -$1.82M – 118
2018
Q4 		$1.82M Sell
28,328
-520
-2% -$38.4K 0.93% 36
2018
Q3 		$2.58M Buy
28,848
+2,785
+11% +$246K 1.07% 30
2018
Q2 		$2.07M Sell
26,063
-75
-0.3% -$6.23K 0.93% 35
2018
Q1 		$2.33K Sell
26,138
-4,342
-14% -$417K 0.99% 28
2017
Q4 		$3.18K Buy
30,480
+65
+0.2% +$7.33K 1.29% 23
2017
Q3 		$4.43M Buy
30,415
+1,383
+5% +$188K 2.19% 11
2017
Q2 		$3.77M Buy
29,032
+2,652
+10% +$325K 1.96% 13
2017
Q1 		$3.28M Buy
26,380
+1,250
+5% +$150K 1.82% 18
2016
Q4 		$2.91M Sell
25,130
-6,930
-22% -$772K 1.68% 18
2016
Q3 		$3.35M Buy
32,060
+550
+2% +$59.5K 2.05% 16
2016
Q2 		$3.11M Buy
31,510
+105
+0.3% +$10.9K 2% 17
2016
Q1 		$3.14M Sell
31,405
-16,635
-35% -$1.71M 2.08% 15
2015
Q4 		$5.75M Buy
48,040
+1,931
+4% +$223K 3.82% 3
2015
Q3 		$4.99M Buy
46,109
+1,490
+3% +$185K 3.66% 4
2015
Q2 		$5.16M Buy
44,619
+865
+2% +$98.9K 3.45% 4
2015
Q1 		$5.04M Buy
43,754
+2,355
+6% +$281K 3.74% 4
2014
Q4 		$4.63M Buy
41,399
+1,840
+5% +$194K 3.68% 4
2014
Q3 		$3.75M Buy
39,559
+1,105
+3% +$99.7K 3.08% 7
2014
Q2 		$3.3M Buy
38,454
+2,280
+6% +$173K 2.82% 8
2014
Q1 		$2.52M Buy
+36,174
New +$2.86M 2.19% 13

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fagan Associates's CELG Position: Q1 2019 in Review

Fagan Associates sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 28,328 shares — an estimated $1.82M sold.

Fagan Associates first reported a position in CELG in Q1 2014 and held it in 20 quarters. The position peaked at $5.75M in Q4 2015. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Fagan Associates reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Fagan Associates sold 28,328 Celgene Corp shares in Q1 2019, an estimated $1.82M.
  • Fagan Associates first reported a position in Celgene Corp in Q1 2014 and held it in 20 quarters.
  • Fagan Associates's Celgene Corp position peaked at $5.75M in Q4 2015.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Fagan Associates's 13F filing for Q1 2019, filed 1 May 2019.